Polycystic ovary syndrome and obesity do not affect vascular parameters related to early atherosclerosis in young women without glucose metabolism disturbances, arterial hypertension and severe abnormalities of lipid profile

Carregando...
Imagem de Miniatura
Citações na Scopus
14
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
INFORMA HEALTHCARE
Citação
GYNECOLOGICAL ENDOCRINOLOGY, v.29, n.4, p.370-374, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The aim of this study was to evaluate the influence of polycystic ovary syndrome (PCOS) and obesity on vascular parameters related to early atherosclerosis (VP-EA) [brachial flow-mediated dilation (FMD), carotid intima-media thickness (CIMT) and carotid arterial compliance (CAC)] in women with minor cardiovascular risk factors (CVRFs). Twenty-five young women with PCOS and 23 eumenorrheic women matched for body mass index (BMI) were studied. The women were subdivided according to BMI and PCOS status, and comparisons were done between PCOS and Control group, regardless of BMI, and between Obese and Lean group, regardless of the presence of PCOS. Insulin resistance was higher in PCOS-group than in control-group and in obese-group than in lean-group. The median of all VP-EA evaluated were similar between PCOS-group and Control-group [FMD: 6.6 versus 8.4% (p = NS); CIMT: 48.0 versus 47.0 mm.10-2 (p = NS); CAC: 6.2 versus 5.6N-1.m4.10-10 (p = NS)] and between obese-group and lean-group [FMD: 7.8 versus 6.6% (p = NS); CIMT: 48.0 versus 47.0 mm.10-2 (p = NS); CAC: 5.7 versus 6.3N-1.m4.10-10 (p = NS)]. These results suggest that PCOS and obesity do not affect VP-EA in women with minor CVRFs.
Palavras-chave
Carotid arterial compliance, carotid intima-media thickness, obesity, polycystic ovary syndrome
Referências
  1. Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178
  2. Barcellos CRG, 2007, ARQ BRAS ENDOCRINOL, V51, P601, DOI 10.1590/S0004-27302007000400015
  3. Bartoli E, 2011, EUR J INTERN MED, V22, P8, DOI 10.1016/j.ejim.2010.07.008
  4. Brinkworth GD, 2006, BJOG-INT J OBSTET GY, V113, P1308, DOI 10.1111/j.1471-0528.2006.01090.x
  5. Coimbra SR, 2005, BRAZ J MED BIOL RES, V38, P1339, DOI 10.1590/S0100-879X2005000900008
  6. DAHLGREN E, 1992, FERTIL STERIL, V57, P505
  7. De Lima JJG, 2002, NEPHROL DIAL TRANSPL, V17, P645, DOI 10.1093/ndt/17.4.645
  8. De Michele M, 2002, STROKE, V33, P2923, DOI 10.1161/01.STR.0000038989.90931.BE
  9. FERRIMAN D, 1961, J CLIN ENDOCR METAB, V21, P1440
  10. Genuth S, 2003, DIABETES CARE, V26, P3160
  11. Juonala M, 2008, EUR HEART J, V29, P1198, DOI 10.1093/eurheartj/ehm556
  12. Kapiotis S, 2006, ARTERIOSCL THROM VAS, V26, P2541, DOI 10.1161/01.ATV.0000245795.08139.70
  13. Lage SG, 2002, AM J PHYSIOL-HEART C, V283, pH3
  14. Mather KJ, 2000, J CLIN ENDOCR METAB, V85, P1851, DOI 10.1210/jc.85.5.1851
  15. Meyer C, 2005, J CLIN ENDOCR METAB, V90, P5711, DOI 10.1210/jc.2005-0011
  16. Oflaz H, 2003, DIABETES NUTR METAB, V16, P176
  17. Orio F, 2004, J CLIN ENDOCR METAB, V89, P4588, DOI 10.1210/jc.2003-031867
  18. Paradisi G, 2001, CIRCULATION, V103, P1410
  19. Prior JO, 2005, CIRCULATION, V111, P2291, DOI 10.1161/01.CIR.0000164232.62768.51
  20. Robinson MR, 2008, J CARDIOVASC MAGN R, V10, DOI [10.1186/1532-429X-10-10, 10.1186/1532-429X-10]
  21. Rocha MP, 2010, FERTIL STERIL, V93, P1948, DOI 10.1016/j.fertnstert.2008.12.044
  22. Rocha MP, 2011, GYNECOL ENDOCRINOL, V27, P814, DOI 10.3109/09513590.2010.508852
  23. Rotterdam EA-SPCWG, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/J.FERTNSTERT.2003.10.004
  24. Sorensen MB, 2006, CLIN ENDOCRINOL, V65, P655, DOI 10.1111/j.1365-2265.2006.02645.x
  25. Talbott EO, 2000, ARTERIOSCL THROM VAS, V20, P2414
  26. Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666
  27. Vryonidou A, 2005, J CLIN ENDOCR METAB, V90, P2740, DOI 10.1210/jc.2004-2363
  28. World Health Organisation and Department of Non-communicable Disease Surveillance, 1999, DEF DIAGN CLASS DI 1
  29. Zawadzki JK, 1992, POLYCYSTIC OVARY SYN, P377
  30. [Anonymous], 2002, CIRCULATION, V106, P3143